Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12
Rodman & Renshaw Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $12
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Maxim Group Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $10
Achieve Life Sciences: Promising Future With Strategic Leadership and Strong Financial Position Justifies Buy Rating
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Oppenheimer Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences Initiated at Strong Buy by Raymond James
Raymond James Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $20
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Buy Rating for Achieve Life Sciences: Strategic Growth and Solid Financials Amidst Leadership Transition
Oppenheimer Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11